{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T01:30:30Z","timestamp":1794274230572,"version":"4.9.0"},"reference-count":121,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2010,6,22]],"date-time":"2010-06-22T00:00:00Z","timestamp":1277164800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2010,8]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Treatment of acute lymphoblastic leukaemia (ALL) in adults presents a formidable challenge. While overall results have improved over the past 3\u2003decades, the long\u2010term survival for patients aged less than 60\u2003years is only in the range of 30\u201340% and is 10\u201315% if between 60 and 70\u2003years and &lt;5% for those over 70\u2003years. The historic lack of clear\u2010cut biological prognostic factors has led to over\u2010 or under\u2010treatment of some patients. Response to initial therapy is an important prognosticator of outcome based on disease biology, as well as pharmacogenetics, which include the patient\u2019s response to drugs given. The more widespread availability of allogeneic transplantation and reduced\u2010intensity regimens for older patients have opened up this curative modality to a greater number of patients. Hopefully, those options, as well as novel cytogenetic and molecular markers, will enable a better selection of patients who undergo intensive therapies and finally break the 30\u201340% cure barrier for adults with ALL.<\/jats:p>","DOI":"10.1111\/j.1365-2141.2010.08246.x","type":"journal-article","created":{"date-parts":[[2010,6,23]],"date-time":"2010-06-23T02:56:20Z","timestamp":1277261780000},"page":"389-405","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":117,"title":["Prognostic factors in adult acute lymphoblastic leukaemia"],"prefix":"10.1111","volume":"150","author":[{"given":"Jacob M.","family":"Rowe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,8,2]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2008.08.025"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-10-184069"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-10-184093"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.11.5253"},{"key":"e_1_2_6_6_1","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1182\/blood.V79.11.3067.3067","article-title":"Bone marrow transplantation for Philadelphia chromosome\u2010positive acute lymphoblastic leukemia","volume":"79","author":"Barrett A.J.","year":"1992","journal-title":"Blood"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1981.tb02684.x"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-07-2708"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2009.268"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2009.011346"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2008.09.001"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199808273390904"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V85.11.3353.bloodjournal85113353"},{"key":"e_1_2_6_14_1","first-page":"3144","article-title":"Analysis of methotrexate and folate transport by multidrug resistance protein 4 (ABCC4): MRP4 is a component of the methotrexate efflux system","volume":"62","author":"Chen Z.S.","year":"2002","journal-title":"Cancer Research"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1995.tb03313.x"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-10-248146"},{"key":"e_1_2_6_17_1","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1182\/blood.V85.5.1151.bloodjournal8551151","article-title":"The biology and treatment of acute lymphoblastic leukemia in adults","volume":"85","author":"Copelan E.A.","year":"1995","journal-title":"Blood"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)10295-1"},{"key":"e_1_2_6_19_1","first-page":"3931","article-title":"Value of immunophenotype in intensively treated adult acute lymphoblastic leukemia: cancer and leukemia Group B study 8364","volume":"93","author":"Czuczman M.S.","year":"1999","journal-title":"Blood"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2009.07.008"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-03-0704"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)04058-6"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature03659"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra020526"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature02626"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V91.11.3995"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11664"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2009.1.353"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2009.015974"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705904"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-05-018192"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-01-199380"},{"key":"e_1_2_6_33_1","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1158\/0008-5472.291.65.1","article-title":"A genome\u2010wide view of the in vitro response to l\u2010asparaginase in acute lymphoblastic leukemia","volume":"65","author":"Fine B.M.","year":"2005","journal-title":"Cancer Research"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04113.x"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24266"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2008.09.003"},{"key":"e_1_2_6_37_1","first-page":"718a","article-title":"Results of a shortened, dose\u2010reduced treatment protocol in elderly patients with acute lymphoblastic leukemia","volume":"96","author":"Gokbuget N.","year":"2000","journal-title":"Blood"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8588(05)70188-X"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-10-116582"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1880"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.21753"},{"key":"e_1_2_6_42_1","first-page":"3135","article-title":"Cytogenetic abnormalities in adult acute lymphoblastic leukemia: correlations with hematologic findings outcome. A Collaborative Study of the Groupe Francais de Cytogenetique Hematologique","volume":"87","author":"Groupe Francais de Cytogenetique Hematologique","year":"1996","journal-title":"Blood"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01002894"},{"key":"e_1_2_6_44_1","first-page":"1537","article-title":"Association of chromosome arm 9p abnormalities with adverse risk in childhood acute lymphoblastic leukemia: a report from the Children\u2019s Cancer Group","volume":"94","author":"Heerema N.A.","year":"1999","journal-title":"Blood"},{"key":"e_1_2_6_45_1","first-page":"295","volume-title":"Neoplastic disease of the blood","author":"Hoelzer D.","year":"1996"},{"key":"e_1_2_6_46_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V64.1.38.38"},{"key":"e_1_2_6_47_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V71.1.123.123"},{"key":"e_1_2_6_48_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V87.2.495.bloodjournal872495"},{"key":"e_1_2_6_49_1","doi-asserted-by":"crossref","first-page":"747a","DOI":"10.1182\/blood.V104.11.2732.2732","article-title":"Subtype adjusted therapy improves outcome of elderly patients with acute lymphoblastic leukemia","volume":"104","author":"Hoelzer D.","year":"2004","journal-title":"Blood"},{"key":"e_1_2_6_50_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa033513"},{"key":"e_1_2_6_51_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2008.07185.x"},{"key":"e_1_2_6_52_1","doi-asserted-by":"publisher","DOI":"10.1097\/01213011-200505000-00002"},{"key":"e_1_2_6_53_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-10-3560"},{"key":"e_1_2_6_54_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-2076"},{"key":"e_1_2_6_55_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2008.07497.x"},{"key":"e_1_2_6_56_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1978.tb05820.x"},{"key":"e_1_2_6_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-4608(98)00153-8"},{"key":"e_1_2_6_58_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-09-241943"},{"key":"e_1_2_6_59_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-05-1735"},{"key":"e_1_2_6_60_1","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2005.1.131"},{"key":"e_1_2_6_61_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2007.11.002"},{"key":"e_1_2_6_62_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.04.012"},{"key":"e_1_2_6_63_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-11-4666"},{"key":"e_1_2_6_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/0277-5379(82)90190-0"},{"key":"e_1_2_6_65_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2009.282"},{"key":"e_1_2_6_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2006.12.010"},{"key":"e_1_2_6_67_1","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2009.1.362"},{"key":"e_1_2_6_68_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-07-2922"},{"key":"e_1_2_6_69_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404101"},{"key":"e_1_2_6_70_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.22.0996"},{"key":"e_1_2_6_71_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-12-128918"},{"key":"e_1_2_6_72_1","doi-asserted-by":"crossref","first-page":"872a","DOI":"10.1182\/blood.V114.22.872.872","article-title":"Comparison of outcomes for non\u2010myeloablative (NMA) and myeloablative (MA) conditioning for adults with acute lymphoblastic leukaemia (ALL) in first and second complete remission (CR): a center for international blood and marrow transplant research (CIBMTR) analysis","volume":"114","author":"Marks D.I.","year":"2009","journal-title":"Blood"},{"key":"e_1_2_6_73_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2009.010306"},{"key":"e_1_2_6_74_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-04-214668"},{"key":"e_1_2_6_75_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.11960"},{"key":"e_1_2_6_76_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-10-051912"},{"key":"e_1_2_6_77_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-07-232124"},{"key":"e_1_2_6_78_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.20.4.1094"},{"key":"e_1_2_6_79_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0808253"},{"key":"e_1_2_6_80_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2009.014274"},{"key":"e_1_2_6_81_1","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2009.1.371"},{"key":"e_1_2_6_82_1","doi-asserted-by":"publisher","DOI":"10.1080\/1042819031000139648"},{"key":"e_1_2_6_83_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1974.tb06770.x"},{"key":"e_1_2_6_84_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2009.07941.x"},{"key":"e_1_2_6_85_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402006"},{"key":"e_1_2_6_86_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428190500331261"},{"key":"e_1_2_6_87_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra052603"},{"key":"e_1_2_6_88_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.12.3768"},{"key":"e_1_2_6_89_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.3.818"},{"key":"e_1_2_6_90_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402111"},{"key":"e_1_2_6_91_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(01)00516-2"},{"key":"e_1_2_6_92_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra023001"},{"key":"e_1_2_6_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60457-2"},{"key":"e_1_2_6_94_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.15.3528"},{"key":"e_1_2_6_95_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-07-037093"},{"key":"e_1_2_6_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2006.08.012"},{"key":"e_1_2_6_97_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2009.75"},{"key":"e_1_2_6_98_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.19.3441"},{"key":"e_1_2_6_99_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-02-267286"},{"key":"e_1_2_6_100_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-05-038950"},{"key":"e_1_2_6_101_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-04-1623"},{"key":"e_1_2_6_102_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.14.3552"},{"key":"e_1_2_6_103_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-07-235143"},{"key":"e_1_2_6_104_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-12-192815"},{"key":"e_1_2_6_105_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-01-024729"},{"key":"e_1_2_6_106_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.d01-2053.x"},{"key":"e_1_2_6_107_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.8.2854"},{"key":"e_1_2_6_108_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2007.07.002"},{"key":"e_1_2_6_109_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2008.09.007"},{"key":"e_1_2_6_110_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2009.00389.x"},{"key":"e_1_2_6_111_1","first-page":"119","article-title":"Philadelphia chromosome positive adult acute lymphoblastic leukemia: characteristics, prognostic factors and treatment outcome","volume":"40","author":"Thomas X.","year":"1998","journal-title":"Hematology and Cell Therapy"},{"key":"e_1_2_6_112_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.1083"},{"key":"e_1_2_6_113_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.10.050"},{"key":"e_1_2_6_114_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21776"},{"key":"e_1_2_6_115_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-04-151860"},{"key":"e_1_2_6_116_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2009.07.005"},{"key":"e_1_2_6_117_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404420"},{"key":"e_1_2_6_118_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1980.tb05907.x"},{"key":"e_1_2_6_119_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-04-1754"},{"key":"e_1_2_6_120_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1102160"},{"key":"e_1_2_6_121_1","first-page":"3983","article-title":"Prospective karyotype analysis in adult acute lymphoblastic leukemia: the cancer and leukemia Group B experience","volume":"93","author":"Wetzler M.","year":"1999","journal-title":"Blood"},{"key":"e_1_2_6_122_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2009.011726"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2010.08246.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.2010.08246.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T12:30:46Z","timestamp":1697373046000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.2010.08246.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":121,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["10.1111\/j.1365-2141.2010.08246.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.2010.08246.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8]]},"assertion":[{"value":"2010-08-02","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}